Jazz Pharmaceuticals Plc (JAZZ)
245.80
+5.32
(+2.21%)
USD |
NASDAQ |
Sep 11, 16:00
245.71
-0.09
(-0.04%)
After-Hours: 20:00
Jazz Pharmaceuticals Price to Book Value : 3.317 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 3.317 |
| September 10, 2026 | 3.245 |
| September 09, 2026 | 3.256 |
| September 08, 2026 | 3.240 |
| September 04, 2026 | 3.331 |
| September 03, 2026 | 3.341 |
| September 02, 2026 | 3.314 |
| September 01, 2026 | 3.289 |
| August 31, 2026 | 3.383 |
| August 28, 2026 | 3.300 |
| August 27, 2026 | 3.389 |
| August 26, 2026 | 3.364 |
| August 25, 2026 | 3.512 |
| August 24, 2026 | 3.434 |
| August 21, 2026 | 3.432 |
| August 20, 2026 | 3.356 |
| August 19, 2026 | 3.403 |
| August 18, 2026 | 3.415 |
| August 17, 2026 | 3.352 |
| August 14, 2026 | 3.306 |
| August 13, 2026 | 3.318 |
| August 12, 2026 | 3.360 |
| August 11, 2026 | 3.346 |
| August 10, 2026 | 3.462 |
| August 07, 2026 | 3.462 |
| Date | Value |
|---|---|
| August 06, 2026 | 3.464 |
| August 05, 2026 | 3.530 |
| August 04, 2026 | 3.531 |
| August 03, 2026 | 3.395 |
| July 31, 2026 | 3.412 |
| July 30, 2026 | 3.487 |
| July 29, 2026 | 3.454 |
| July 28, 2026 | 3.467 |
| July 27, 2026 | 3.447 |
| July 24, 2026 | 3.426 |
| July 23, 2026 | 3.440 |
| July 22, 2026 | 3.379 |
| July 21, 2026 | 3.431 |
| July 20, 2026 | 3.286 |
| July 17, 2026 | 3.340 |
| July 16, 2026 | 3.268 |
| July 15, 2026 | 3.230 |
| July 14, 2026 | 3.212 |
| July 13, 2026 | 3.198 |
| July 10, 2026 | 3.290 |
| July 09, 2026 | 3.332 |
| July 08, 2026 | 3.350 |
| July 07, 2026 | 3.343 |
| July 06, 2026 | 3.295 |
| July 02, 2026 | 3.286 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Avadel Pharmaceuticals Plc | -- |
| Perrigo Co. Plc | 0.7531 |
| GH Research Plc | 5.194 |
| Cosmo NV | -- |
| Axsome Therapeutics, Inc. | 138.59 |
Price to Book Value Related Metrics
| PE Ratio | 16.95 |
| PS Ratio | 3.480 |
| Price to Free Cash Flow | 10.62 |
| Price | 245.80 |
| Earnings Yield | 5.90% |
| Market Cap | 15.93B |
| Operating PE Ratio | 16.76 |
| Normalized PE Ratio | 14.75 |